122 related articles for article (PubMed ID: 9785334)
1. Recombinant human erythropoietin in the anaemia of multiple myeloma and non-Hodgkin's lymphoma.
San Miguel JF; García-Sanz R
Med Oncol; 1998 Aug; 15 Suppl 1():S29-34. PubMed ID: 9785334
[TBL] [Abstract][Full Text] [Related]
2. [Recombinant human erythropoietin in the treatment of anemia associated with lymphoproliferative diseases--chronic lymphadenosis and multiple myeloma].
Haber J; Spicka I; Petruzelka L; Kolesková E; Straub J; Jonásová A; Pospísilová B
Vnitr Lek; 1996 Apr; 42(4):262-7. PubMed ID: 8693713
[TBL] [Abstract][Full Text] [Related]
3. The role of recombinant human erythropoietin in the management of anaemic cancer patients: focus on haematological malignancies.
Osterbor A
Med Oncol; 2000 Nov; 17 Suppl 1():S17-22. PubMed ID: 11188781
[TBL] [Abstract][Full Text] [Related]
4. Recombinant human erythropoietin in the anemia associated with multiple myeloma or non-Hodgkin's lymphoma: dose finding and identification of predictors of response.
Cazzola M; Messinger D; Battistel V; Bron D; Cimino R; Enller-Ziegler L; Essers U; Greil R; Grossi A; Jäger G; LeMevel A; Najman A; Silingardi V; Spriano M; van Hoof A; Ehmer B
Blood; 1995 Dec; 86(12):4446-53. PubMed ID: 8541533
[TBL] [Abstract][Full Text] [Related]
5. [Tumor anemia. Overview of the role of human recombinant erythropoietin (r-hu-EPO) in treatment of tumor anemia].
Monnerat C; Leyvraz S
Praxis (Bern 1994); 1999 Jan; 88(5):178-88. PubMed ID: 10067375
[TBL] [Abstract][Full Text] [Related]
6. Use of erythropoietin in patients with multiple myeloma.
Egerer G; Harter C; Karthaus M; Ho AD; Goldschmidt H
Onkologie; 2003 Feb; 26(1):80-4. PubMed ID: 12624523
[TBL] [Abstract][Full Text] [Related]
7. Recombinant human erythropoietin for the treatment of chronic anemia in multiple myeloma and squamous cell carcinoma.
Ludwig H; Pecherstorfer M; Leitgeb C; Fritz E
Stem Cells; 1993 Sep; 11(5):348-55. PubMed ID: 8241947
[TBL] [Abstract][Full Text] [Related]
8. Anemia in multiple myeloma.
Ludwig H; Pohl G; Osterborg A
Clin Adv Hematol Oncol; 2004 Apr; 2(4):233-41. PubMed ID: 16163188
[TBL] [Abstract][Full Text] [Related]
9. Safety and efficacy of recombinant human erythropoietin treatment of anaemia associated with multiple myeloma in haemodialysed patients.
Ruedin P; Pechère Bertschi A; Chapuis B; Benedet P; Leski M
Nephrol Dial Transplant; 1993; 8(4):315-8. PubMed ID: 8390005
[TBL] [Abstract][Full Text] [Related]
10. Recombinant human erythropoietin in transfusion-dependent anemic patients with multiple myeloma and non-Hodgkin's lymphoma--a randomized multicenter study. The European Study Group of Erythropoietin (Epoetin Beta) Treatment in Multiple Myeloma and Non-Hodgkin's Lymphoma.
Osterborg A; Boogaerts MA; Cimino R; Essers U; Holowiecki J; Juliusson G; Jäger G; Najman A; Peest D
Blood; 1996 Apr; 87(7):2675-82. PubMed ID: 8639883
[TBL] [Abstract][Full Text] [Related]
11. Prediction of response to treatment with recombinant human erythropoietin in anaemia associated with cancer.
Beguin Y
Med Oncol; 1998 Aug; 15 Suppl 1():S38-46. PubMed ID: 9785336
[TBL] [Abstract][Full Text] [Related]
12. Recombinant human erythropoietin and the anemia of multiple myeloma.
Barlogie B; Beck T
Stem Cells; 1993 Mar; 11(2):88-94. PubMed ID: 8457789
[TBL] [Abstract][Full Text] [Related]
13. Anemia and infections in multiple myeloma: supportive therapy.
Cáceres W; Santiago K; Paulo L; Román J
Bol Asoc Med P R; 2009; 101(2):50-2. PubMed ID: 19954102
[TBL] [Abstract][Full Text] [Related]
14. Treatment of the anemia of multiple myeloma: the role of recombinant human erythropoietin.
Barlogie B
Semin Hematol; 1993 Oct; 30(4 Suppl 6):25-7. PubMed ID: 8153675
[TBL] [Abstract][Full Text] [Related]
15. Erythropoietin treatment of the anaemia of myelofibrosis with myeloid metaplasia: results in 20 patients and review of the literature.
Cervantes F; Alvarez-Larrán A; Hernández-Boluda JC; Sureda A; Torrebadell M; Montserrat E
Br J Haematol; 2004 Nov; 127(4):399-403. PubMed ID: 15521916
[TBL] [Abstract][Full Text] [Related]
16. [Anemia in lymphoma].
de La Motte Rouge T; Schneider M
Bull Cancer; 2005 May; 92(5):429-31. PubMed ID: 15932805
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of anaemia in patients with malignancy: implications for the clinical use of recombinant human erythropoietin.
Cazzola M
Med Oncol; 2000 Nov; 17 Suppl 1():S11-6. PubMed ID: 11188780
[TBL] [Abstract][Full Text] [Related]
18. Recombinant human erythropoietin in cancer-related anemia: an evidence-based review.
Desai J; Demetri GD
Best Pract Res Clin Haematol; 2005; 18(3):389-406. PubMed ID: 15792913
[TBL] [Abstract][Full Text] [Related]
19. A multi-center open-labeled study of recombinant erythropoietin-beta in the treatment of anemic patients with multiple myeloma, low-grade non-Hodgkin's lymphoma, or chronic lymphocytic leukemia in Chinese population.
Yang S; Jun M; Hong-Li Z; Jian-Min W; Chun W; Lu-Gui Q; Yong-Qiang Z; Jun Z; Jian H; Zhi-Xiang S
Int J Hematol; 2008 Sep; 88(2):139-144. PubMed ID: 18629603
[TBL] [Abstract][Full Text] [Related]
20. Erythropoietin (r-HuEPO) in the treatment of anemia of nodular sclerosis type Hodgkin's disease--a preliminary report.
Wojtukiewicz MZ; Sawicki Z; Radziwon P
Rocz Akad Med Bialymst; 2000; 45():145-9. PubMed ID: 11712426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]